Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Helicobacter Pylori and Acute Alcohol Induced Pancreatitis

This study has been completed.
Sponsor:
Information provided by:
University of Tampere
ClinicalTrials.gov Identifier:
NCT00490386
First received: June 20, 2007
Last updated: June 21, 2007
Last verified: June 2007
  Purpose

This study is performed to measure wether Helicobacter Pylori has an effect on the incidence and course of acute alcohol induced pancreatitis


Condition
Pancreatitis, Acute
Helicobacter Infections

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Cross-Sectional
Official Title: Alkoholihaimatulehduksen Uusiminen

Resource links provided by NLM:


Further study details as provided by University of Tampere:

Enrollment: 100
Study Start Date: June 2006
Detailed Description:

A recent pilot study unexpectedly discovered, that Helicobacter pylori infection was rare in patients having their first acute alcohol induced pancreatitis (AAIP) when compared to subjects with similar alcohol use but no history of pancreatitis. This subject has not been studied in humans until now. Therefore we seek to study, with a larger material, wether AAIP is associated with lower prevalence of Helicobacter pylori, by measuring the antibodies against Helicobacter pylori from the sera of AAIP patients and from a control group of alcoholics with no history of AAIP.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Acute alcohol pancreatitis (first)

Exclusion Criteria:

  • Death during hospitalization
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00490386

Locations
Finland
Tampere University Hospital
Tampere, Pirkanmaa, Finland
Sponsors and Collaborators
University of Tampere
Investigators
Principal Investigator: Jahangir A Khan, MS Department of Gastroenterology and Alimentary Tract Surgery, Tampere University
Study Director: Isto Nordback, MD 1Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00490386     History of Changes
Other Study ID Numbers: R00126-1
Study First Received: June 20, 2007
Last Updated: June 21, 2007
Health Authority: Finland: Ethics Committee

Keywords provided by University of Tampere:
Retrospective
Length of Stay
Helicobacter pylori

Additional relevant MeSH terms:
Helicobacter Infections
Pancreatitis
Pancreatitis, Alcoholic
Alcohol-Induced Disorders
Alcohol-Related Disorders
Bacterial Infections
Chemically-Induced Disorders
Digestive System Diseases
Gram-Negative Bacterial Infections
Pancreatic Diseases
Substance-Related Disorders

ClinicalTrials.gov processed this record on November 25, 2014